Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Smit

Showing results (781-790 of 881) with videos related to

Pageof 89
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R StudyNicolas Girard, Jair Bar, Pilar Garrido, et al.
Transboundary and Emerging Diseases|September 27, 2022
SARS-CoV-2 infection in dogs and cats is associated with contact to COVID-19-positive household membersMarleen M Kannekens-Jager, Myrna M T de Rooij, Yasmina de Groot, et al.
Lancet (London, England)|March 9, 2010
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialR A Nout, V T H B M Smit, H Putter, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884)Berthe M P Aleman, Théodore Girinsky, Richard W M van der Maazen, et al.
The Journal of Antimicrobial Chemotherapy|January 21, 2022
Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countriesDongsheng Yang, Dick J J Heederik, Dik J Mevius, et al.
Nature Microbiology|July 25, 2018
Abundance and diversity of the faecal resistome in slaughter pigs and broilers in nine European countriesPatrick Munk, Berith Elkær Knudsen, Oksana Lukjancenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation CarriersAlexandra J van den Broek, Laura J van 't Veer, Maartje J Hooning, et al.
British Journal of Cancer|January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistryLisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2009
Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trialRemi A Nout, Hein Putter, Ina M Jürgenliemk-Schulz, et al.
The Journal of Molecular Diagnostics : JMD|June 25, 2018
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor TissueMarthe M de Jonge, Dina Ruano, Ronald van Eijk, et al.
Pageof 89

Showing results (781-790 of 881) with videos related to

Sort By:
Pageof 89
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R StudyNicolas Girard, Jair Bar, Pilar Garrido, et al.
Transboundary and Emerging Diseases|September 27, 2022
SARS-CoV-2 infection in dogs and cats is associated with contact to COVID-19-positive household membersMarleen M Kannekens-Jager, Myrna M T de Rooij, Yasmina de Groot, et al.
Lancet (London, England)|March 9, 2010
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialR A Nout, V T H B M Smit, H Putter, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884)Berthe M P Aleman, Théodore Girinsky, Richard W M van der Maazen, et al.
The Journal of Antimicrobial Chemotherapy|January 21, 2022
Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countriesDongsheng Yang, Dick J J Heederik, Dik J Mevius, et al.
Nature Microbiology|July 25, 2018
Abundance and diversity of the faecal resistome in slaughter pigs and broilers in nine European countriesPatrick Munk, Berith Elkær Knudsen, Oksana Lukjancenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation CarriersAlexandra J van den Broek, Laura J van 't Veer, Maartje J Hooning, et al.
British Journal of Cancer|January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistryLisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2009
Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trialRemi A Nout, Hein Putter, Ina M Jürgenliemk-Schulz, et al.
The Journal of Molecular Diagnostics : JMD|June 25, 2018
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor TissueMarthe M de Jonge, Dina Ruano, Ronald van Eijk, et al.
Pageof 89